- ►annals.org PA Bunn, SJ Hoffman, D Norris, LE Golitz, JL … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To review recent studies of systemic therapy for mycosis ... Cited by 162 - Related articles - BL Direct - All 3 versions
- ►jcojournal.org [PDF] RO Dillman, R Mick, OR McIntyre - Journal of Clinical Oncology, 1989 - jcojournal.org From the University of California San Diego School of Medicine, La Jolla;
Harvard School of Public Health, Boston; and Norris Cotton Cancer Center,
Hanover, NH. Submitted August 1, 1988; accepted November 16, 1988. This ... Cited by 106 - Related articles - All 6 versions
- ►ascopubs.org [PDF] J Mercieca, E Matutes, C Dearden, K … - Journal of Clinical Oncology, 1994 - jco.ascopubs.org Purpose: To assess the results of treatment with the purine analog
2'deoxycoformycin (pentostatin [DCF]) in patients with postthymic T-cell
malignancies. Patients and Methods: One hundred forty-five pa- tients with ... Cited by 103 - Related articles - BL Direct - All 6 versions
A Saven, L Piro - The New England journal of medicine, 1994 - nejm.highwire.org Hairy-cell Leukemia, or leukemic reticuloendotheliosis, is an uncommon chronic
lymphoproliferative disorder first described by Bouroncle et al. in 1958 1 . Its
defining features are mononuclear cells with prominent cytoplasmic ... Cited by 86 - Related articles - BL Direct - All 5 versions
L Bergmann, K Fenchel, B Jahn, PS Mitrou, D … - Annals of Oncology, 1993 - Eur Soc Med Oncology Page 1. Annals of Oncology 4: 371-375. 1993. O 1993 Klmver Academic Publishers.
Printed in the Netherlands. Original article Immunosuppressive ... Cited by 73 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org [PDF] EH Kraut, MR Grever, BA Bouroncle - Blood, 1994 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 63 - Related articles - BL Direct - All 4 versions
- ►ascopubs.org [PDF] FM Foss, DC Ihde, IR Linnoila, AB Fischmann … - Journal of Clinical Oncology, 1994 - jco.ascopubs.org Purpose: This phase II study was undertaken to as- sess tee efficacy and
toxicity of the addition of continuous low-dose interferon alfa-2a (IFN) to
fludarabine in pa- tients with advanced or refractory mycosis fungoides ... Cited by 62 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org [PDF] FJ Cummings, K Kim, RS Neiman, RL Comis, … - Journal of Clinical Oncology, 1991 - jco.ascopubs.org Thirty-seven patients with refractory lymphoma or cutaneous T-cell lymphoma were
treated with 2'- deoxycoformycin (pentostatin; dCF), 5 mg/m2 intrave- nous (IV)
bolus for 3 consecutive days of every 3-week cycle in this Eastern ... Cited by 62 - Related articles - All 7 versions
- ►oxfordjournals.org [PDF] AD Ho, J Thaler, P Stryckmans, B Coiffier, M … - JNCI Journal of the National Cancer Institute, 1990 - jnci.oxfordjournals.org Pentostatin was used to treat 26 patients with advanced B-cell chronic lympho-
cytic leukemia resistant to conventional treatment. Twenty patients had pro-
gressive disease on previous regimens and six had had partial remission and ... Cited by 60 - Related articles - All 5 versions
E Montserrat, C Rozman - Annals of Oncology, 1995 - Eur Soc Med Oncology Chronic lymphocytic leukemia (CLL) is the form of leuke- mia which occurs most
frequently in Western countries. Its etiology is unknown, and no relationship
with viruses or genes has been demonstrated. Epidemiological data suggest ... Cited by 61 - Related articles - BL Direct - All 3 versions
